Virax Biolabs
VRAX
VRAX
5 hedge funds and large institutions have $1.14M invested in Virax Biolabs in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$858K | |
| 2 | -$35K | |
| 3 | -$11K | |
| 4 |
Renaissance Technologies
New York
|
-$8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.17K |